Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion type Assertion NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_head.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion wasGeneratedBy ECO_0000203 NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_provenance.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion wasDerivedFrom befree-2016 NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_provenance.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion SIO_000772 19705967 NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_provenance.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion evidence source_evidence_literature NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_provenance.
- NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_assertion description "[All ptHL expressed CD15, CD30 and LMP-1 of EBV; the B-cell markers BOB-1, Oct2, CD79a and CD20 were more commonly expressed in ptHL versus cHL (100%, 86%, 50% and 38% in ptHL compared to 6%, 14%, 10% and 33% in cHL, respectively); all ptHL expressed phosphoinositide 3-kinase (PI3K) versus 81% of cHL; 2/6 (33%) ptHL displayed gains at 9p24 that were similar to cHL (32%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759332.RAgP51ykM6noCfYKybiSHTC3fwP25PmC4XIU_t4JeOHqg130_provenance.